251 related articles for article (PubMed ID: 25078269)
1. Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease.
Freeman CM; Stolberg VR; Crudgington S; Martinez FJ; Han MK; Chensue SW; Arenberg DA; Meldrum CA; McCloskey L; Curtis JL
PLoS One; 2014; 9(7):e103840. PubMed ID: 25078269
[TBL] [Abstract][Full Text] [Related]
2. Altered effector function of peripheral cytotoxic cells in COPD.
Urbanowicz RA; Lamb JR; Todd I; Corne JM; Fairclough LC
Respir Res; 2009 Jun; 10(1):53. PubMed ID: 19545425
[TBL] [Abstract][Full Text] [Related]
3. Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.
Urbanowicz RA; Lamb JR; Todd I; Corne JM; Fairclough LC
Respir Res; 2010 Jun; 11(1):76. PubMed ID: 20540777
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD.
Roos-Engstrand E; Pourazar J; Behndig AF; Blomberg A; Bucht A
Respir Res; 2010 Sep; 11(1):128. PubMed ID: 20863413
[TBL] [Abstract][Full Text] [Related]
5. Lung Dendritic Cells Drive Natural Killer Cytotoxicity in Chronic Obstructive Pulmonary Disease via IL-15Rα.
Finch DK; Stolberg VR; Ferguson J; Alikaj H; Kady MR; Richmond BW; Polosukhin VV; Blackwell TS; McCloskey L; Curtis JL; Freeman CM
Am J Respir Crit Care Med; 2018 Nov; 198(9):1140-1150. PubMed ID: 29676596
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
7. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).
Wang J; Urbanowicz RA; Tighe PJ; Todd I; Corne JM; Fairclough LC
PLoS One; 2013; 8(3):e58556. PubMed ID: 23505535
[TBL] [Abstract][Full Text] [Related]
10. Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent.
Freeman CM; McCubbrey AL; Crudgington S; Nelson J; Martinez FJ; Han MK; Washko GR; Chensue SW; Arenberg DA; Meldrum CA; McCloskey L; Curtis JL
PLoS One; 2014; 9(5):e96421. PubMed ID: 24805101
[TBL] [Abstract][Full Text] [Related]
11. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease.
Borchers MT; Wesselkamper SC; Curull V; Ramirez-Sarmiento A; Sánchez-Font A; Garcia-Aymerich J; Coronell C; Lloreta J; Agusti AG; Gea J; Howington JA; Reed MF; Starnes SL; Harris NL; Vitucci M; Eppert BL; Motz GT; Fogel K; McGraw DW; Tichelaar JW; Orozco-Levi M
J Clin Invest; 2009 Mar; 119(3):636-49. PubMed ID: 19197141
[TBL] [Abstract][Full Text] [Related]
12. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
13. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus).
Watanabe M; Kudo Y; Kawano M; Nakayama M; Nakamura K; Kameda M; Ebara M; Sato T; Nakamura M; Omine K; Kametani Y; Suzuki R; Ogasawara K
Int Immunol; 2014 Nov; 26(11):597-606. PubMed ID: 24860119
[TBL] [Abstract][Full Text] [Related]
14. CD56
Ma M; Yin X; Zhao X; Guo C; Zhu X; Liu T; Yang M; Zhang Z; Fu Y; Liu J; Xu J; Ding H; Han X; Chu Z; Shang H; Jiang Y
J Leukoc Biol; 2019 Dec; 106(6):1313-1323. PubMed ID: 31483071
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.
Popescu I; Drummond MB; Gama L; Coon T; Merlo CA; Wise RA; Clements JE; Kirk GD; McDyer JF
Am J Respir Crit Care Med; 2014 Oct; 190(7):744-55. PubMed ID: 25137293
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease.
Barczyk A; Pierzchała W; Kon OM; Cosio B; Adcock IM; Barnes PJ
J Allergy Clin Immunol; 2006 Jun; 117(6):1484-92. PubMed ID: 16751017
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
[TBL] [Abstract][Full Text] [Related]
18. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
[TBL] [Abstract][Full Text] [Related]
19. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
20. HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes.
Baxevanis CN; Gritzapis AD; Tsitsilonis OE; Katsoulas HL; Papamichail M
Int J Cancer; 2002 Apr; 98(6):864-72. PubMed ID: 11948464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
